PharmaCyte Biotech, Inc. (PMCB) › Operating Cash FlowPharmaCyte Biotech, Inc. (PMCB) — Operating Cash FlowAnnual figures by period end, from SEC filings.2011-04-30: -$225.2K2012-04-30: -$259.3K2013-04-30: -$390.4K2017-04-30: -$3.34M2018-04-30: -$5.08M2019-04-30: -$2.88M2020-04-30: -$2.34M2021-04-30: -$3.33M2022-04-30: -$4.12M2023-04-30: -$3.79M2024-04-30: -$2.15M2025-04-30: -$2.98M2026-04-30: -$5.15M-$5.15M2011-04-30Operating Cash Flow (USD)2026-04-30Period endedOperating Cash FlowChange YoYSource filing2026-04-30-$5.15M—2026-07-29From 2025-05-012025-04-30-$2.98M—2026-07-29From 2024-05-012024-04-30-$2.15M—2025-08-11From 2023-05-012023-04-30-$3.79M—2024-08-13From 2022-05-012022-04-30-$4.12M—2023-07-31From 2021-05-012021-04-30-$3.33M—2022-07-28From 2020-05-012020-04-30-$2.34M—2021-08-10From 2019-05-012019-04-30-$2.88M—2020-08-13From 2018-05-012018-04-30-$5.08M—2019-08-13From 2017-05-012017-04-30-$3.34M—2018-07-20From 2016-05-012013-04-30-$390.4K—2013-07-29From 2012-05-012012-04-30-$259.3K—2013-07-29From 2011-05-012011-04-30-$225.2K—2012-08-14From 2010-05-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)